Fatigue, a multifaceted clinical symptom, often presents a diagnostic challenge for healthcare professionals due to its subjective nature and broad differential diagnosis. Understanding the underlying causes and adopting a comprehensive approach is crucial for effective management.
Fatigue can be classified into physical and mental fatigue. Physical fatigue is a lack of energy or strength, while mental fatigue is characterized by a decrease in sustained cognitive performance. It's essential to differentiate between the two as their etiologies and management strategies may differ.
A thorough patient history and physical examination form the cornerstone of fatigue evaluation. Key considerations include duration, severity, impact on daily activities, and associated symptoms. It's also crucial to explore psychosocial factors, sleep patterns, dietary habits, and medication use.
Lab investigations should be guided by clinical suspicion. Basic tests include complete blood count, thyroid function tests, and metabolic panel. In cases where fatigue is unexplained or persistent, more advanced investigations like sleep studies or neuroimaging may be warranted.
Management should be tailored to the identified cause. Non-pharmacologic interventions, including lifestyle modifications, cognitive-behavioral therapy, and graded exercise therapy, have shown effectiveness. Pharmacologic therapy may be considered in specific conditions.
Decoding fatigue requires a comprehensive, patient-centered approach. By understanding its complexities and adopting a structured assessment and management strategy, healthcare professionals can effectively address this common yet often overlooked symptom. Continued research is needed to further elucidate the pathophysiology of fatigue and develop more targeted therapies.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation